title: The diflunisal trial: update on study drug tolerance and disease progression.
authors.affiliation: Amyloid Treatment & Research Program, Boston Medical Center, Boston, MA, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Berk
authors.forename: P J
authors.initials: PJ
authors.lastname: Dyck
authors.forename: L
authors.initials: L
authors.lastname: Obici
authors.forename: S R
authors.initials: SR
authors.lastname: Zeldenrust
authors.forename: Y
authors.initials: Y
authors.lastname: Sekijima
authors.forename: T
authors.initials: T
authors.lastname: Yamashita
authors.forename: Y
authors.initials: Y
authors.lastname: Ando
authors.forename: S-I
authors.initials: SI
authors.lastname: Ikeda
authors.forename: P
authors.initials: P
authors.lastname: Gorevic
authors.forename: G
authors.initials: G
authors.lastname: Merlini
authors.forename: J W
authors.initials: JW
authors.lastname: Kelly
authors.forename: M
authors.initials: M
authors.lastname: Skinner
authors.forename: A B
authors.initials: AB
authors.lastname: Bisbee
authors.forename: O B
authors.initials: OB
authors.lastname: Suhr
mesh_terms: D017772:Amyloid Neuropathies / Q000188:drug therapy* / Q000235:genetics; D018450:Disease Progression; D004361:Drug Tolerance; D006801:Humans